Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Health and Risk Factors in Patients With Hip and Knee Osteoarthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03438630
Recruitment Status : Active, not recruiting
First Posted : February 20, 2018
Last Update Posted : May 27, 2020
Sponsor:
Collaborators:
Linkoeping University
Jonkoping County Hospital
Information provided by (Responsible Party):
Vastra Gotaland Region

Brief Summary:
Hip and knee osteoarthritis is one of the leading causes of global disability. There is no cure for the disease, but research and guidelines recommends that patients with osteoarthritis, early after the diagnosis, receive individually adapted physical exercises, information about their disease and about self-management and, if needed, recommendations on weight loss as a core treatment to prevent disability and impairment in health. This core treatment improves symptoms in osteoarthritis by reducing pain and increasing function, and have the potential to delay replacement surgery. In Sweden, core treatment has since 2008, been standardized in a supported self-management programme and evaluation and follow-ups are registered in the National Quality Register BOA (Better management of patients with OsteoArthritis). The course of deterioration in pain and physical functioning among different individuals with osteoarthritis is currently difficult to predict. Factors such as socioeconomic status and comorbidity contribute to progression of the disease, but are not fully established. There is a need for early identification of individuals who have a good prognosis with slow disease development and those that should be recommended joint replacement surgery in the future. Overriding aim of the study is to increase knowledge about the population who has received education and supervised exercises as a core treatment for hip and knee osteoarthritis and been registered in the BOA Register and to identify factors that can predict long-term outcome for this population.

Condition or disease
Osteoarthritis

Detailed Description:

Study design: This is a nationwide observational cohort study using prospectively obtained individual-level register data from five main sources; the BOA Register, the Swedish Hip Arthroplasty Register (SHAR), the Swedish Knee Arthroplasty Register (SKAR), Statistics Sweden and the National Board of Health and Welfare, Sweden. By using the personal identity number (PIN) that is unique to all citizens in Sweden, data will be merged together to create a research database that will be used for answering the following research questions in the study:

  1. What are the differences between the population included in the BOA Register and the general Swedish population regarding health and socioeconomic factors?
  2. What factors that predicts replacement surgery can be identified at the first registration in the BOA Register in patients with hip or knee osteoarthritis?
  3. What factors that predicts outcome after replacement surgery can be identified at the first registration in the BOA Register in patients with hip or knee osteoarthritis?

Study population:The study cohort consists of all patients with a first registration (baseline) in the BOA Register between 2008 and 2016 (approximately n=75 000). These patients have sought treatment for knee and/or hip pain in primary health care in Sweden and been referred to the standardized core treatment of education and supervised exercises after confirmed clinical and/or radiographic osteoarthritis diagnose.

A control cohort (approximately n=225 000) covering the general Swedish population, who never have been included in the BOA register, will be recruited from the Swedish population register at Statistics Sweden and matched (1:3) to each patient in the study cohort by the same year of birth, gender and residence (as for the study cohort at baseline).

Data sources: In the study the investigators will collect the following data from the five registers: from the BOA Register: data reported by patients (e.g. most affected joint, pain, symptoms, health-related quality of life and physical activity level) and physiotherapists (e.g. earlier examinations and treatments) at baseline (the first registration before the standardized core treatment), and three and 12 months after. From the SHAR and the SKAR: patient-related and procedure-related data on all hip- and knee replacement surgeries in Sweden, including patient-reported outcomes (PROM) such as joint pain, health-related quality of life and satisfaction with treatment before surgery and one year postoperatively. From Statistics Sweden: data on socioeconomic factors and vital events such as birth, death, residence and marital status. From the National Board of Health and Welfare: data on comorbidity, health care consumption and expenditures of prescribed drugs.

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 288276 participants
Observational Model: Case-Control
Time Perspective: Other
Target Follow-Up Duration: 5 Years
Official Title: Health and Risk Factors in Patients With Hip and Knee Osteoarthritis
Actual Study Start Date : January 2008
Actual Primary Completion Date : December 2016
Estimated Study Completion Date : December 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Osteoarthritis

Group/Cohort
Study cohort
All patients with a first registration (baseline) in the BOA Register between 2008 and 2016 (approximately n=75 000). These patients have sought treatment for knee and/or hip pain in primary health care in Sweden and been referred to the standardized core treatment of education and supervised exercises after confirmed clinical and/or radiographic OA diagnose.
Control cohort
Covering the general Swedish population, who never have been included in the BOA register, will be recruited from the Swedish population register at Statistics Sweden and matched (1:3) to each patient in the study cohort by the same year of birth, gender and residence (as for the study cohort at baseline) (approximately n=225 000).



Primary Outcome Measures :
  1. Replacement surgery [ Time Frame: up to the end of 2016 ]
    Information from the SHAR and the SKAR Registers on eventual replacement surgery


Secondary Outcome Measures :
  1. Socioeconomic factors - marital status [ Time Frame: at baseline ]
    Data obtained from Statistics Sweden on marital status

  2. Socioeconomic factors - education level [ Time Frame: at baseline ]
    Data obtained from Statistics Sweden on education level

  3. Socioeconomic factors - country of birth [ Time Frame: at baseline ]
    Data obtained from Statistics Sweden on country of birth

  4. Socioeconomic factors - occupation [ Time Frame: at baseline ]
    Data obtained from Statistics Sweden on occupation

  5. Socioeconomic factors - income [ Time Frame: within three years prior to baseline ]
    Data obtained from Statistics Sweden on income

  6. Socioeconomic factors - sick leave [ Time Frame: within three years prior to baseline ]
    Data obtained from Statistics Sweden on sick leave

  7. Consumption of drugs [ Time Frame: within three years prior to baseline ]
    Data on expenditures of prescribed drugs from the Swedish Prescribed Drug Register at the National Board of Health Care, Sweden

  8. Death [ Time Frame: up to the end of 2016 ]
    eventually registered as dead by Statistics Sweden

  9. Comorbidity [ Time Frame: within three years prior to baseline ]
    Data from the National Board of Health and Welfare on registered ICD10-codes

  10. Health care consumption [ Time Frame: within three years prior to baseline ]
    Data from the National Board of Health and Welfare on admission and discharge dates from health care units

  11. Comorbidity [ Time Frame: within three years prior to baseline ]
    Data from the National Board of Health and Welfare on registered classification of surgical interventions

  12. Patient-reported outcome measure on most affected joint [ Time Frame: at baseline, and at three and 12 months ]
    Data from the BOA Register on most affected joint

  13. Patient-reported outcome measure on fear avoidance [ Time Frame: at baseline, and at three and 12 months ]
    Data from the BOA Register on fear avoidance

  14. Patient-reported outcome measure on physical activity [ Time Frame: at baseline, and at three and 12 months ]
    Data from the BOA Register on physical activity level measured by questionnaire "In a typical week, how much time do you spend doing physical activity"

  15. Patient-reported outcome measure on satisfaction with treatment [ Time Frame: at baseline, and at three and 12 months ]
    Data from the BOA Register on satisfaction with treatment (the standardized core treatment) results measured by questionnaire

  16. Patient-reported outcome measure musculoskeletal comorbidity [ Time Frame: at baseline, and at three and 12 months ]
    Data from the BOA Register on musculoskeletal comorbidity measured in Charnley class (classifications of musculoskeletal impairment. Class A corresponds with unilateral hip or knee osteoarthritis (OA); Class B bilateral hip or knee OA; and Class C indicates multiple joint OA or some other condition that inhibits the patient's ability to walk)

  17. Patient-reported outcome measure on pain [ Time Frame: at baseline, and at three and 12 months ]
    Data from the BOA Register on pain in most affected joint, measured on VAS; (visual analogue scale) rating from 0-100, were 0 stands for no pain and 100 for maximum pain

  18. Patient-reported outcome measure on health-related quality of life [ Time Frame: at baseline, and at three and 12 months ]
    Data from the BOA Register on health-related quality of life measured by EuroQol 5-domain instrument (EQ-5D). The instrument consists of questions assessing 5 health outcome domains; mobility, self-care, usual activities, pain/discomfort and anxiety/ depression, and is summarized into a single score between 0 and 1 (full health). The instrument also includes a VAS assessing current overall health state scoring from 0 (worst imaginable health state) to 100 (best imaginable health state).

  19. Patient-reported outcome measure on self-efficacy [ Time Frame: at baseline, and at three and 12 months ]
    Data from the BOA Register on self-efficacy on ASES (Arthritis self-efficacy scale). ASES is a self-administered questionnaire which contains 11 items divided into 2 subgroups, self-efficacy pain and self-efficacy other symptoms. Each question is scored from 10 to 100, with "moderately certain" place midway between "very uncertain" and "very certain". Each subscale is scored separately, by taking the mean of the subscale items.

  20. Physiotherapist-reported earlier examinations [ Time Frame: at baseline and at three months ]
    Data from the BOA Register on earlier examinations of the affected joint prior to the standardized core treatment

  21. Physiotherapist-reported earlier interventions [ Time Frame: at baseline and at three months ]
    Data from the BOA Register on earlier interventions, prior to the standardized core treatment

  22. Physiotherapist-reported compliance with intervention [ Time Frame: at baseline and at three months ]
    Data from the BOA Register on compliance with the standardized core treatment intervention

  23. Patient-reported outcome measures on satisfaction with treatment [ Time Frame: before replacement surgery and at follow up one year ]
    Data from the SHAR and the SKAR Register on satisfaction with treatment (replacement surgery)

  24. Patient-reported outcome measures - musculoskeletal comorbidity [ Time Frame: before replacement surgery and at follow up one year ]
    Data from the SHAR and the SKAR Register on musculoskeletal comorbidity measured by Charnley class (Class A corresponds to unilateral hip/knee disease; Class B bilateral hip/knee disease; and Class C indicates multiple joint disease or some other condition that inhibits the patient's ability to walk).

  25. Patient-reported outcome measures - pain [ Time Frame: before replacement surgery and at follow up one year ]
    Data from the SHAR and the SKAR Register on pain from a VAS; visual analogue scale rating from 0-100, were 0 stands for no pain and 100 for maximum pain

  26. Patient-reported outcome measures - health-related quality of life [ Time Frame: before replacement surgery and at follow up one year ]
    Data from the SHAR and the SKAR Register on health-related quality of life measured by EuroQol 5-domain instrument (EQ-5D). The instrument consists of questions assessing 5 health outcome domains; mobility, self-care, usual activities, pain/discomfort and anxiety/ depression, and is summarized into a single score between 0 and 1 (full health). The instrument also includes a VAS assessing current overall health state scoring from 0 (worst imaginable health state) to 100 (best imaginable health state).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
The population who has received standardized core treatment of education and supervised exercises for hip and knee osteoarthritis and been registered in the BOA Register
Criteria

Inclusion Criteria: for participation in the standardized core treatment (of education and supervised exercises) and registration in the BOA Register are;

  • pain from the knee or hip.
  • diagnosis of osteoarthritis confirmed by a physical therapist, by medical history and a physical examination based on the clinical criteria for osteoarthritis

Exclusion Criteria: for participation in the standardized core treatment and registration in the BOA Register are;

  • confirmed or suspicion of tumor, rheumatoid arthritis, sequel hip fracture, chronic pain or fibromyalgia,
  • total joint replacement within the past 12 months,
  • other surgery of the knee or hip joint within the past 3 months,
  • not able to read or understand Swedish

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03438630


Locations
Layout table for location information
Sweden
Vastra Gotaland
Gothenburg, Sweden
Sponsors and Collaborators
Vastra Gotaland Region
Linkoeping University
Jonkoping County Hospital
Investigators
Layout table for investigator information
Principal Investigator: Ola Rolfson, Ass profess Vastra Gotaland
Additional Information:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Vastra Gotaland Region
ClinicalTrials.gov Identifier: NCT03438630    
Other Study ID Numbers: 160176
First Posted: February 20, 2018    Key Record Dates
Last Update Posted: May 27, 2020
Last Verified: May 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Vastra Gotaland Region:
socioeconomic factors
comorbidity
replacement surgery
Additional relevant MeSH terms:
Layout table for MeSH terms
Osteoarthritis
Osteoarthritis, Knee
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases